Valuation Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 12:20:00 2026-10-30 EDT			5-day change	1st Jan Change
50.00 ^DKK	+1.32%		+1.83%	+38.12%

10-26	DNB Carnegie raises target price for Lundbeck to 58 Danish kroner (54), reiterates buy	FW
10-21	BNP Paribas raises price target for Lundbeck to 48 Danish kroner (46), reiterates neutral	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	25,433	31,719	39,416	41,398	53,167	-	-
Change	-	24.72%	24.27%	5.03%	28.43%	-	-
Enterprise Value (EV) ¹	27,464	31,008	51,598	49,619	57,098	52,949	49,145
Change	-	12.91%	66.4%	-3.84%	15.07%	-7.27%	-7.18%
P/E	13.5x	14.2x	13x	13.4x	11.8x	11.7x	12.7x
PBR	1.24x	1.47x	1.64x	1.72x	1.89x	1.7x	1.56x
PEG	-	0.7x	0.3x	8.5x	0.3x	10.23x	-1.56x
Capitalization / Revenue	1.39x	1.59x	1.79x	1.68x	2.05x	2.02x	2.08x
EV / Revenue	1.51x	1.56x	2.34x	2.01x	2.2x	2.01x	1.92x
EV / EBITDA	5.89x	5.49x	8.13x	6.3x	6.94x	6.44x	6.42x
EV / EBIT	9.63x	9.71x	15.8x	9.41x	9.31x	8.4x	8.47x
EV / FCF	10.2x	8.66x	18.7x	10.2x	9.67x	8.64x	8.79x
FCF Yield	9.83%	11.5%	5.35%	9.8%	10.3%	11.6%	11.4%
Dividend per Share ²	0.58	0.7	0.95	1.15	1.57	1.385	1.476
Rate of return	2.23%	2.14%	2.3%	2.66%	2.88%	2.54%	2.71%
EPS ²	1.93	2.31	3.17	3.22	4.611	4.664	4.285
Distribution rate	30.1%	30.3%	30%	35.7%	34.1%	29.7%	34.4%
Net sales ¹	18,246	19,912	22,004	24,630	25,997	26,287	25,587
EBITDA ¹	4,663	5,652	6,347	7,881	8,230	8,226	7,653
EBIT ¹	2,852	3,195	3,270	5,275	6,132	6,300	5,805
Net income ¹	1,916	2,290	3,143	3,192	4,620	4,670	4,313
Net Debt ¹	2,031	-711	12,182	8,221	3,931	-218	-4,021
Reference price ²	26.05	32.76	41.32	43.16	54.55	54.55	54.55
Nbr of stocks (in thousands)	992,840	992,840	992,011	991,227	991,227	-	-
Announcement Date	2/7/23	2/7/24	2/5/25	2/4/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	41.54x	14.06x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	38.61x	8.62x	17.83x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	109.15x	6.06x	25.73x	2.28%	369B
NOVARTIS AG	23.19x	5.97x	14.41x	2.71%	307B
ASTRAZENECA PLC	24.47x	4.9x	13.63x	1.77%	290B
AMGEN INC.	29.56x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-49.1x	7.47x	29.35x	1.93%	212B
Average	31.02x	7.40x	19.73x	2.01%	473.55B
Weighted average by Cap.	37.29x	8.84x	21.96x	1.69%